At the time of writing, AVITA Medical Inc [RCEL] stock is trading at $12.80, down -3.10%. An important factor to consider is whether the stock is rising or falling in short-term value. The RCEL shares have gain 8.94% over the last week, with a monthly amount drifted -0.16%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
AVITA Medical Inc [NASDAQ: RCEL] stock has seen the most recent analyst activity on December 24, 2024, when D. Boral Capital initiated its Buy rating and assigned the stock a price target of $25. Previously, BTIG Research downgraded its rating to Neutral on April 11, 2024. On June 27, 2023, Cantor Fitzgerald initiated with a Overweight rating and assigned a price target of $23 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $27 on March 02, 2021. BofA Securities initiated its recommendation with a Buy and recommended $42 as its price target on August 27, 2020. Oppenheimer started tracking with a Outperform rating for this stock on April 21, 2020, and assigned it a price target of $9. In a note dated March 03, 2020, BTIG Research initiated an Buy rating and provided a target price of $10 on this stock.
For the past year, the stock price of AVITA Medical Inc fluctuated between $7.51 and $18.93. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. AVITA Medical Inc [NASDAQ: RCEL] shares were valued at $12.80 at the most recent close of the market. An investor can expect a potential drop of -29.69% based on the average RCEL price forecast.
Analyzing the RCEL fundamentals
According to AVITA Medical Inc [NASDAQ:RCEL], the company’s sales were 60.04M for trailing twelve months, which represents an 43.25% jump. Gross Profit Margin for this corporation currently stands at 0.82% with Operating Profit Margin at -0.8%, Pretax Profit Margin comes in at -0.77%, and Net Profit Margin reading is -0.77%. To continue investigating profitability, this company’s Return on Assets is posted at -0.27, Equity is -0.4 and Total Capital is -0.31. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.51 points at the first support level, and at 12.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.22, and for the 2nd resistance point, it is at 13.64.
Ratios To Look Out For
It is important to note that AVITA Medical Inc [NASDAQ:RCEL] has a current ratio of 3.73. On the other hand, the Quick Ratio is 3.37, and the Cash Ratio is 1.7. Considering the valuation of this stock, the price to sales ratio is 5.30, the price to book ratio is 27.45.
Transactions by insiders
Recent insider trading involved O’Toole David D, CFO, that happened on Dec 05 ’24 when 975.0 shares were purchased. CFO, O’Toole David D completed a deal on May 30 ’24 to buy 1000.0 shares. Meanwhile, CFO O’Toole David D bought 1250.0 shares on Feb 28 ’24.
